Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions

癌症代谢和肿瘤宿主相互作用博士后培训项目

• 批准号: 10596510
• 负责人: Yibin Kang
• 金额: $ 29.89万
• 依托单位: RUTGERS BIOMEDICAL AND HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10596510
• 关键词: Training Programs; host neoplasm interaction; post-doctoral training; tumor metabolism

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings together an exceptional group of investigators organized in multi-disciplinary research teams focusing on a broad spectrum of cancer research. The Cancer Metabolism and Growth (CMG) Program, at RCINJ has robust research strengths bolstered by strong collaboration between researchers at Rutgers and our formal consortium partner Princeton University. The proposed program leverages these unique research strengths and resources of RCINJ to provide training in translational research in Cancer Metabolism and Growth and Tumor Host Interactions. The primary goal of this T32 training program is to provide postdoctoral candidates with the highest quality training and research experience so that they are competitive in developing research careers in academia, government, and the private sector. To achieve this goal, trainees will engage in mentored cancer research, co-curricular and professional career development activities for two years. Program candidates are Ph.D. recipients who wish to develop careers in cancer research. The program will recruit a cohort of 2 new trainees each year from year 1-5. Thus, the program will have 2 trainees in year 1 and 4 trainees in year 2 through 5 of the training grant. High achieving post-doctoral fellows (evidenced by research productivity in the form of number of publications, fellowship awards, presentations etc.), may be supported for an additional third year of training through institutional funds. Faculty members with active, well-funded research programs and extensive mentoring experience will support program trainees. All of the faculty mentors chosen for this program have significant R01-level peer reviewed funding in tumor metabolism and host interactions focused research. Experienced leadership team with track-record of research productivity and mentoring will ensure successful implementation of the program. Both formative and summative evaluation will be integral parts of the proposed program. We will annually track the educational and professional activities of trainees for at least 10 years after completing research training. We will disseminate results from the comprehensive evaluation on the program website. Additional dissemination will occur through articles published in peer-reviewed journals and through presentations at regional and national conferences, by program staff as well as participants. Our program benefits from the multi-disciplinary research environment and robust educational resources available at RCINJ (the state's only NCI designated Comprehensive Cancer Center) as well as the consortium relationship with Princeton University. 19

新泽西州罗格斯癌症研究所(RCINJ)为基础、 临床、行为或基于人群的癌症研究，汇集了一批杰出的 研究人员组织在多学科研究团队中，专注于广泛的癌症研究。 RCINJ的癌症代谢和生长计划(CMG)拥有强大的研究实力，得到了 罗格斯大学的研究人员和我们的正式联盟合作伙伴普林斯顿大学之间的密切合作。 拟议的计划利用RCINJ的这些独特的研究优势和资源来提供培训 在癌症代谢和生长以及肿瘤宿主相互作用的翻译研究中。初级阶段 该T32培训计划的目标是为博士后候选人提供最高质量的培训和 研究经验，使他们在发展学术界、政府、 和私营部门。为了实现这一目标，受训人员将参与有指导的癌症研究、联合课程 以及两年的职业生涯发展活动。计划候选人是获得博士学位的人 希望在癌症研究方面发展事业。该计划每年将招聘2名新学员，从 1-5年级。因此，该方案将在第一年有2名实习生，在第二到第五年有四名实习生。 格兰特。高成就博士后研究员(以以下形式的研究生产率为证 出版物、研究金奖励、演示文稿等)，可额外支持第三年的培训 通过机构基金。教职员工具有积极的、资金充足的研究计划和广泛的 指导经验将为项目实习生提供支持。为这个项目选择的所有教师导师都有 重要的R01水平的同行评审资金集中在肿瘤代谢和宿主相互作用的研究中。 经验丰富的领导团队，拥有研究效率和指导的记录，将确保成功 该方案的实施。形成性评价和总结性评价都将是拟议的 程序。我们将每年跟踪学员的教育和专业活动至少10年。 在完成研究培训后。我们会公布综合评估的结果。 计划网站。将通过发表在同行评议期刊上的文章和 通过在区域和国家会议上的发言，由方案工作人员以及与会者进行。我们的 计划受益于多学科的研究环境和强大的教育资源 在RCINJ(该州唯一的NCI指定的综合癌症中心)以及财团 与普林斯顿大学的关系。 19